



Thyroxine is the main secretory hormone of thyroid gland and it is produced in 
thyroglobulin by thyroid peroxidase/hydrogen peroxide/iodide system. After biosynthesis 
and secretion of thyroxine, it undergoes multiple metabolic reactions. The most important 
metabolic pathway is the stepwise deiodination from the inner ring or outer ring. 
Removal of one of the outer ring or phenolic ring iodines of biologically less active T4, 
leads to the formation of 3,5,3'-triiodothyronine or T3, a compound which is biologically 
more active. On the other hand, removal of one of the inner ring or tyrosyl ring iodines 
gives 3,3',5'-triiodothyronine (3,3',5'-T3 or rT3) which is a biologically inactive thyroid 
hormone. Three enzymes involved in this activation and inactivation pathway of thyroid 
hormones are known as iodothyronine deiodinases (IDs), which are dimeric integral-
membrane selenoproteins. Depending upon the sequence and substrate specificity, three 
iodothyronine deiodinase enzymes have been identified, iodothyronine deiodinase-1  
 
Scheme 1. Inner- and outer-ring deiodinations of thyroxine (T4) catalyzed by three 
iodothyronine deiodinases (ID-1, ID-2 and ID-3). 
(ID-1), iodothyronine deiodinase-2 (ID-2) and iodothyronine deiodinase-3 (ID-3). ID-1 
can catalyze both inner ring and outer ring deiodination of thyroid hormones whereas, 
ID-2 is selective to the outer ring deiodination. The type-1 and -2 deiodinases (ID-1 and 
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ID-2) produces the biologically active hormone 3,5,3′-triiodothyronine (T3). These two 
enzymes also convert 3,3′,5′-triiodothyronine (reverse T3 or rT3) to 3,3′-diiodothyronine 
(3,3′-T2) by outer-ring deiodination (Scheme 1). The type-3 deiodinase (ID-3) catalyzes 
the convertion of T4 to rT3 by an inner-ring deiodination pathway. 
 Apart from deiodination, there are several alternate pathways of thyroid hormone 
metabolism, which include sulfate conjugation and glucoronidation of the phenolic 
hydroxyl group of iodothyronines, the oxidative deamination and decarboxylation of the 
alanine side chain to form thyroacetic acid and thyronamines, respectively. 
Glucoronidation and sulfate conjugation changes the physico-chemical properties of 
iodothyronines dramatically. 
 This thesis consists of five chapters. The first chapter provides a general 
introduction of biosynthesis of thyroid hormones and followed by deiodination by three 
iodothyronine deiodinase enzyme. This chapter also provides an overview of thyroid 
hormone transport and different transport proteins and their mode of binding with thyroid 
hormones. Apart from this, this chapter also provides a brief overview on other thyroid 
hormone metabolites.  
 In the second chapter of the thesis, initial attempts in the development of 
different iodothyronine deiodinase mimics have been discussed. Goto et al have shown 
that the sterically hindered selenol 1 converts the thyroxine derivative 3 (N-
butyrylthyroxine methyl ester) to the corresponding triiodo derivative 4 by an outer-ring 
deiodination (Scheme 2). Although the reaction was carried out in organic solvent and a 
relatively higher temperature (50 °C) and longer reaction time (7 days) were required for 
about 65% deiodination, this study also provides an experimental evidence for the 
formation of selenenyl iodide (2) in the deiodination of a thyroxine derivative by an 
organoselenol. However, only one iodine was removed from the outer ring of 3, no inner 
ring deiodination was detected (Scheme 2). 
 Interestingly, when compound 5 was treated with selenol 1 under similar 
conditions, no deiodination was observed (Scheme 3). This leads to assumption that 
presence of free phenolic hydroxyl group is important for the deiodinase activity. Based 
on this experimental observation, they proposed a mechanism which involves an enol-
v 
 
keto tautomerism of the phenolic hydroxyl group. In the case of thyroxine, the outer-ring 
can undergo enol-keto tautomerism, whereas due to lack of free hydroxyl group, the inner 
ring cannot undergo similar kind of tautomerism. The enol-keto tautomerism probably 
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Scheme 2. Deiodination of thyroxine derivative 3 by selenol 1. 
 
 
Scheme 3. (A) Attempted deiodination of 5 by selenol 1 and (B) Mechanism for the 
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respectively. However, introduction of a secondary amine adjacent to the selenol moiety 
into the compound 9 significantly reduces the deiodinase activity. 
 In the third chapter synthesis, deiodinase activity and mechanism of 
deiodination of a series of peri-substituted naphthalene derivatives is discussed. 
Iodobenzene was used as halogen bond donor for the DFT calculations. From the orbital 
analysis it is observed that there is perfect orbital symmetry match between the HOMO of 
compound 8 (selenolate form) and LUMO of iodobenzene. When the selenolate form of 
1-selenonaphthol interacts with iodobenzene, a halogen bonded adduct is formed. The 
negative charge on the selenium center decreases as it donates electron pair to the σ* 
orbital of C–I bond in iodobenzene and as a consequence the positive charge on the 
iodine center decreases (Figure 1). Addition of iodobenzene to 1-selenonaphthol led to a 
significant downfield shift in 77Se NMR spectrum of 1-selenonaphthol and with an 
increase in the concentration of iodobenzene, more downfield shift in the signal was 
observed. 
 
Figure 1. The charges obtained from Natural Bond Orbital (NBO) analysis for the 
selenolate form of (a) 1-selenonaphthol (b) iodobenzene, (c) halogen-bonded adduct  
On the basis of experimental end theoretical data, a mechanism for the deiodination of T4 
by compound 8 is proposed. According to the mechanism, the initial interaction of one of 
the selenol moieties with an iodine leads to the formation of halogen bond. The transfer 









partial positive charge on the selenium atom, which facilitates an interaction between the 
halogen bonded selenium atom and the free selenol (selenolate) moiety (intermediate 12). 
The selenium−selenium interaction (chalcogen bond) strengthens the halogen bond, 
leading to a heterolytic cleavage of the C−I bond. The protonation of the resulting 
carbanion leads to the formation of rT3. On the other hand, the formation of an Se−Se 
bond produces the diselenide 13 with elimination of iodide as HI. The reductive cleavage 
of the Se−Se bond in compound 13 regenerates the diselenol 8 (Figure 2). 
 
Scheme 5. Proposed mechanism for the deiodination of thyroxine (T4) by compound 8 
involving chalcogen and halogen bonding. 
In the fourth chapter deiodination of sulfated thyroid hormones is discussed. 
Sulfate conjugation is an important step in in the irreversible inactivation of thyroid 
hormones. Sulfate conjugation of the phenolic hydroxyl group stimulates the inner ring 
deiodination of T4 and T3 but it blocks the outer ring deiodination of T4 by ID-1. The 
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thyroxine sulfate (T4S) undergoes faster deiodination as compared to the parent thyroid 
hormone T4. Only ID-1 catalyzes the deiodination of sulfated thyroid hormones. In 
contrast, ID-2 and ID-3 do not accept T4S and/or T3S as substrate. We have shown that 
iodothyronine sulfates can be readily deiodinated by synthetic deiodinase model 
compound 8 and its derivatives. In contrast to the inner ring-selective deiodination of T4, 
the synthetic compounds loses the selectivity and mediate both inner and outer-ring 
deiodination of T4S and outer ring deiodination of rT3S. From this study, we have also 
proposed that the enol-keto tautomerism is probably not required for the outer ring 
deiodination and the strength of halogen bonding controls the regioselective deiodination 
by model compounds.  
 In the fifth chapter, the mechanism of inhibition of iodothyronine 
deiodinases by PTU and IAA is discussed with the help of model compounds. In the 
model study, it has been observed that compound 8 does not form a stable Se-I 
intermediate (14), which is essential for the formation of Se-S covalent bond with PTU. 
As a consequence, the deiodination of T4 by compound 8 is not inhibited by PTU. This 
study supports the proposal that ID-3 does not follow a ping-pong bi-substrate pathway 
for deiodination and may not form a stable E-Se-I intermediate, which is responsible for 
the insensitivity of ID-3 towards PTU. 
 
Scheme 6. Proposed mechanism of insensitivity of (a) model compound 8 and (b) ID-3 
towards PTU inhibition. 
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The biphenyl based diselenol 15 reacts with IAA and iodoacetamide to form the 
corresponding carboxymethylated product 17. On the other hand, compound 8 does not 
undergo the expected carboxymethylation by IAA and iodoacetamide, but they readily 
deiodinate both IAA and iodoacetamide. Based on this model study, a possible model is 
proposed for the insensitivity of ID-3 towards IAA.  
 
Scheme 7. Reaction of IAA with compounds 15 (a) and 8 (b). 
Iopanoic acid (18) is a well known radiocontrast agent and is used as adjunctive 
therapy with PTU and CBZ for the treatment of thyrotoxicosis.[9] We show in this chapter 
that iopanoic acid undergoes monodeiodination by compound 8 under physiological 
relevant conditions. The deiodinated products (19 and 20) from iopanoic acid are 
characterized by NMR spectroscopy and single crystal X-ray crystallography. It is 
observed that after monodeiodination, the strength of halogen bonding decreases and 
therefore, the monodeiodinated products do not undergo further deiodination. 
 
Scheme 8. Deiodination of iopanoic acid by compound 8. 
